Upgrade

60 Degrees Pharmaceuticals, Inc

SXTPW

Last
$0.02
Day
-14.6%
1y
-6.5%
5y
-97.0%
52w
-84.2%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.03
EMA 50
0.03
EMA 200
0.05
20d high
-37.6%
5y high
-98.5%
5y range
1th

Positions held

Your positions

SXTPW isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
-27
Hold
avoid
Signal
Strong Sell
Target
$0.03
Stop
$0.02
Stop distance
18.7%
Target vs last
+21.9%

Fundamentals

Market cap—Enterprise value—Trailing P/E—Forward P/E—
PEG—Price / book-0.01Beta—Dividend yield—
Revenue growth—Earnings growth—Gross margin—Operating margin—
Profit margin—ROE—ROA—Debt / equity—
Current ratio—Free cash flow—Analyst recommendationnoneMean target—
52w high$0.0352w low$0.02

Quarterly

2026-Q22026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$0.2M$0.2M$0.3M$0.4M$0.1M—
Op margin-1092.4%-1292.5%-632.0%-531.4%-1591.5%—
Net income-$2.3M-$2.1M-$1.4M-$2.3M-$1.7M—
Gross margin27.3%47.1%60.2%-22.9%50.4%—
Gross profit$0.1M$0.1M$0.2M-$0.1M$0.1M—
Operating income-$2.3M-$2.1M-$1.9M-$2.3M-$1.6M—
  • Revenue +28% vs prior quarter ($0.2M vs $0.2M).
  • Gross margin 27.3% (was 47.1% prior quarter).
  • Operating margin expanded to -1092.4%.

Yearly (6y)

20252024202320222021
Revenue$1.0M$0.6M$0.3M$0.2M—
Op margin-771.6%-1599.0%-2032.8%-784.2%—
Net income-$7.4M-$7.9M-$3.8M-$6.2M—
Gross margin22.3%36.7%-87.1%-93.7%—
Gross profit$0.2M$0.2M-$0.2M-$0.2M—
Operating income-$7.8M-$9.7M-$5.2M-$1.8M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

SXTPW · daily-29.7% over 12 sessions
Close EMA21 EMA50 EMA200
0.020.030.030.040.042026-092026-092026-092026-092026-092026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$2M-$2M-$1M-$0M$0M-1591%-766%60%2025-Q22025-Q32025-Q42026-Q12026-Q2